Amivantamab-Lazertinib Ups Survival in EGFR-Mutated Advanced Lung Cancer
Improved progression-free survival seen for amivantamab-lazertinib versus osimertinib as first-line treatment
FDA Study Shows Pasteurization Kills Bird Flu in Milk
By Robin Foster HealthDay Reporter
MONDAY, July 1, 2024 (HealthDay News) -- As bird flu continues to spread among U.S. dairy cows, reassuring new government...
Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea
Significantly lower risk of major adverse cardiovascular events, all-cause mortality seen in metabolic surgery group
Clinical Response Seen for Patients With Severe Asthma Initiating Biologics
Responses more frequent in initiators than noninitiators, but 40 to 50 percent of initiators did not meet response criteria
CDC Strengthens RSV Vaccine Advice for Those Over 75
By Robin Foster HealthDay Reporter
THURSDAY, June 27, 2024 (HealthDay News) -- In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all...
ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSA
Two randomized controlled trials show reduction in AHI; significant improvements seen in all secondary end points
Smoking + RA With Obstructive Pattern Shows Less Spirometry Decline
Whereas patients with RA who never smoked had more decline in percent-predicted forced expiratory volume in one second
Summer COVID Cases Are Rising Across America
By Robin Foster HealthDay Reporter
TUESDAY, June 25, 2024 (HealthDay News) -- As scorching summer temperatures drive Americans indoors and millions travel for vacations and...
FDA Expands Approval for Duchenne Muscular Dystrophy Gene Therapy
Approval allows for use in nonambulatory individuals ≥4 years with a confirmed gene mutation
Aerobic Exercise Tied to Improved Clinical Asthma Outcomes
Benefits include asthma-related quality of life and asthma control
